Once Weekly Dulaglutide Enhances β-Cell Function Compared to Metformin in Patients with Type 2 Diabetes (T2DM)

被引：0
|
作者：
Mari, Andrea [1 ]
Del Prato, Stefano [2 ]
Ludvik, Bernhard [3 ]
de la Pena, Amparo [4 ]
Shurzinske, Linda [4 ]
Pechtner, Valeria [5 ]
机构：
[1] CNR, Inst Biomed Engn, Padua, Italy
[2] Univ Pisa, Pisa, Italy
[3] Med Univ Vienna, Vienna, Austria
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Eli Lilly & Co, Neuilly Sur Seine, France
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP40-3
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy by Baseline BMI with Once Weekly Dulaglutide in Chinese T2DM Patients
    Shi, Yongquan
    Zhang, Bin
    Wu, Haiya
    [J]. DIABETES, 2019, 68
  • [2] Pharmacokinetics of Once Weekly Dulaglutide in Patients with Type 2 Diabetes Mellitus
    De la Pena, Amparo
    Loghin, Corina
    Cui, Xuewei
    Zhang, Xin
    Geiser, Jeanne S.
    Martin, Jennifer A.
    Chien, Jenny Y.
    [J]. DIABETES, 2014, 63 : A251 - A252
  • [3] Pharmacokinetics of once weekly dulaglutide in patients with type 2 diabetes mellitus
    de la Pena, A.
    Loghin, C.
    Cui, X.
    Zhang, X.
    Geiser, J. S.
    Martin, J.
    Chien, J. Y.
    [J]. DIABETOLOGIA, 2014, 57 : S349 - S349
  • [4] COST-EFFECTIVENESS OF ONCE WEEKLY DULAGLUTIDE 1.5 MG VERSUS ONCE DAILY LIRAGLUTIDE 1.8 MG FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN CHINA
    Han, S.
    Guo, W. J.
    Wang, K.
    McKaig, S.
    Strizek, A. A.
    Shi, L. W.
    [J]. VALUE IN HEALTH, 2019, 22 : S167 - S167
  • [5] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    [J]. ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
  • [6] Two-Year Use of Exenatide Once Weekly in Type 2 Diabetes Mellitus (T2DM) Patients Taking Thiazolidinedione
    Trautmann, Michael
    Norwood, Paul
    Pintilei, Ella
    Liutkus, Joanne
    Haber, Harry
    Boardman, Marilyn
    [J]. DIABETES, 2012, 61 : A293 - A293
  • [7] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)
    Johns, D
    Herz, M
    Tan, MH
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    [J]. DIABETES, 2002, 51 : A102 - A102
  • [8] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
    Ross, Stuart A.
    Haak, Thomas
    Patel, Sanjay
    Thiemann, Sandra
    Schumacher, Helmut
    Meinicke, Thomas
    [J]. DIABETES, 2014, 63 : A277 - A277
  • [9] The Usage of Metformin Despite of Existing Contraindications in Type 2 Diabetes Mellitus (T2DM) Patients
    Kosmalski, Marcin
    Drozdowska, Agata
    Drzewoski, Jozef
    [J]. DIABETES, 2011, 60 : A311 - A312
  • [10] Empagliflozin (EMPA) Compared with Glimepiride (GLIM) as Add-on to Metformin (MET) for 2 Years in Patients with Type 2 Diabetes (T2DM)
    Ridderstrale, Martin
    Andersen, Knut Robert
    Zeller, Cordula
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2014, 63 : A70 - A70
12345